Alessandra Ferrario - Concepedia

Author

Alessandra Ferrario

London School of Economics and Political Science ORCID

Also Known As

A Ferrario, A. Ferrario, A. Turato & V. Ferrario, Alessandra Ferrario, Ferrario, Alessandra

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

London School of Economics and Political Science University of Strathclyde University of Liverpool World Health Organization Regional Office for Europe Harvard University

About

Alessandra Ferrario is an author at London School of Economics and Political Science specializing in health policy, health economics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Business	8	8	541
2	Medicine	8	8	256
3	Law	1	1	171
4	Management	1	1	67
5	Nursing	1	1	13

Alessandra Ferrario

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Managed entry agreements for pharmaceuticals: the European experience Alessandra Ferrario, Panos Kanavos London School of Economics and Political Science Research Online (London School of Economics and Political Science) Mergers And AcquisitionsRegulatory ApprovalEntry AgreementsBusinessLaw	2013	171
Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden Alessandra Ferrario, Panos Kanavos Social Science & Medicine Barrier To EntryEconomicsHealth EconomicsManaged Entry AgreementsPharmaceutical Practice	2014	154
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, PharmacoEconomics	2017	117
Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs Panos Kanavos, Alessandra Ferrario, Sotiris Vandoros, Health Affairs	2013	107
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs Rickard E. Malmström, Brian Godman, Eduard Diogène, Frontiers in Pharmacology	2013	91
Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications M. M. Nashilongo, Bonifasius Siyuka Singu, Francis Kalemeera, Cardiovascular Drugs and Therapy	2017	88
Managing Risk and Uncertainty in Health Technology Introduction: The Role of Managed Entry Agreements Panos Kanavos, Alessandra Ferrario, Giovanni Tafuri, Global Policy Mea SRisk AnalysisHealth Care FinanceNew TherapiesRisk Management	2017	67
Strategies to achieve fairer prices for generic and biosimilar medicines Alessandra Ferrario, Guillaume Dedet, Tifenn Humbert, BMJ Market DesignPricing PolicyOrphan DrugAntitrust EnforcementDrug Interactions	2020	66
Global access to quality-assured medical products: the Oxford Statement and call to action Paul N. Newton, Katherine C. Bond, Paul N. Newton, The Lancet Global Health	2019	52
Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications Joseph Fadare, Kazeem A. Oshikoya, Olayinka O. Ogunleye, Hospital Practice	2018	47

Page 1